Low- and high-dose radioiodine therapy for low-/intermediate-risk differentiated thyroid cancer: a preliminary clinical trial

被引：0
|
作者：
Yuan Qu
Rui Huang
Lin Li
机构：
[1] West China Hospital of Sichuan University,Department of Nuclear Medicine
来源：
Annals of Nuclear Medicine | 2017年 / 31卷
关键词：
Thyroid neoplasms; Thyroidectomy; Iodine radioisotopes; Radiotherapy dosage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：71 / 83
页数：12
相关论文
共 50 条
  • [21] Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer
    Koichiro Abe
    Umiko Ishizaki
    Toshihiro Ono
    Kiyomi Horiuchi
    Kazuko Kanaya
    Shuji Sakai
    Takahiro Okamoto
    Annals of Nuclear Medicine, 2020, 34 : 144 - 151
  • [22] Active surveillance in low- and intermediate-risk prostate cancer
    Cerbone, Linda
    Regine, Giovanni
    Calabro, Fabio
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 582 - 583
  • [23] Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer
    Nixon, Iain J.
    Ganly, Ian
    FUTURE ONCOLOGY, 2013, 9 (07) : 921 - 923
  • [24] Low-Dose-Rate Brachytherapy Versus Cryotherapy in Low- and Intermediate-Risk Prostate Cancer
    Gestaut, Matthew M.
    Cai, Wendi
    Vyas, Shilpa
    Patel, Belur J.
    Hasan, Salman A.
    MunozMaldonado, Yolanda
    Deb, Niloyjyoti
    Swanson, Gregory
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 101 - 107
  • [25] Long-Term Outcome of Low- and High-Dose Radioiodine for Thyroid Remnant Ablation
    Liu, Shiqi
    Wu, Shuqi
    Ma, Chao
    Wang, Shaoyan
    Chen, Suyun
    Wang, Hui
    Feng, Fang
    CLINICAL ENDOCRINOLOGY, 2024, 101 (06) : 682 - 689
  • [26] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
  • [27] Multi-Institutional Phase 2 Trial of High-Dose Stereotactic Body Radiation Therapy with Temporary Hydrogel Spacer for Low- and Intermediate-Risk Prostate Cancer
    Folkert, M. R.
    Zelefsky, M. J.
    Hannan, R.
    Desai, N. B.
    Lotan, Y.
    Laine, A. M.
    Kim, D. W. N.
    Hardee, S.
    Hornberger, B.
    Kollmeier, M. A.
    McBride, S.
    Xie, X. J.
    Roehrborn, C.
    Timmerman, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1319 - 1320
  • [28] Thyroidectomy without Radioiodine in Low- Risk Thyroid Cancer Reply
    Leboulleux, Sophie
    Schlumberger, Martin-Jean
    Borget, Isabelle
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (22): : 2155 - 2155
  • [29] Testosterone kinetics after proton therapy for low- and intermediate-risk prostate cancer
    Nichols, Romaine Charles
    Morris, Christopher G.
    Hoppe, Bradford S.
    Henderson, Randal H.
    Mendenhall, William M.
    Li, Zuofeng
    Williams, Christopher R.
    Costa, Joseph A.
    Harris, Stephanie
    Mendenhall, Nancy Price
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [30] Ablation with Low-Dose versus High-Dose Radioiodine in differentiated Thyroid Cancer
    Elrasad, S. A. A.
    Elhoseini, M. A.
    Abdelmeguid, R.
    Elrefaei, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S540 - S540
12345